Racial representativeness of cancer clinical trials sponsored by the National Cancer Institute compared to pharmaceutical companies

被引：0
|
作者：
Unger, Joseph M. [1 ]
Hershman, Dawn L. [2 ]
Osarogiagbon, Raymond U. [3 ]
Gothwal, Anirudh [4 ]
Anand, Seerat [5 ]
Dasari, Arvind [5 ]
Overnman, Michael [5 ]
Loree, Jonathan M. [6 ]
Raghav, Kanwal [5 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[2] Columbia Univ, New York, NY USA
[3] Baptist Canc Ctr, Memphis, TN USA
[4] Baylor Univ, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[6] BC Canc, Vancouver, BC, Canada
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-4344
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4344
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Analysis of esophagogastric cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase 1 trials
    Bando, Hideaki
    Rubinstein, Larry
    Harris, Pamela
    Yoshino, Takayuki
    Doi, Toshihiko
    Ohtsu, Atsushi
    Welch, John
    Takebe, Naoko
    GASTRIC CANCER, 2017, 20 (03) : 481 - 488
  • [32] Analysis of esophagogastric cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase 1 trials
    Hideaki Bando
    Larry Rubinstein
    Pamela Harris
    Takayuki Yoshino
    Toshihiko Doi
    Atsushi Ohtsu
    John Welch
    Naoko Takebe
    Gastric Cancer, 2017, 20 : 481 - 488
  • [33] Breast cancer vaccines: ongoing National Cancer Institute-registered clinical trials
    Mittendorf, Elizabeth A.
    Alatrash, Gheath
    Xiao, Haile
    Clifton, G. Travis
    Murray, James L.
    Peoples, George E.
    EXPERT REVIEW OF VACCINES, 2011, 10 (06) : 755 - 774
  • [34] Adolescent and young adult enrollment to a National Cancer Institute-sponsored National Clinical Trials Network Research Group over 25 years
    Unger, Joseph M.
    Beauchemin, Melissa
    Hershman, Dawn L.
    CANCER, 2021, 127 (24) : 4574 - 4584
  • [35] A National Cancer Clinical Trials Network: Recommendations From the Institute of Medicine
    Nass, Sharyl J.
    Balogh, Erin
    Mendelsohn, John
    AMERICAN JOURNAL OF THERAPEUTICS, 2011, 18 (05) : 382 - 391
  • [36] The National Cancer Institute's Experimental Therapeutics Clinical Trials Network
    Ivy, S. Percy
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (03) : 144 - 146
  • [37] NATIONAL-CANCER-INSTITUTE COOPERATIVE CLINICAL-TRIALS PROGRAM
    WEISS, RB
    JACOBS, EM
    CA-A CANCER JOURNAL FOR CLINICIANS, 1979, 29 (05) : 287 - 290
  • [38] National Cancer Institute Begins Revamp of Clinical Trials Cooperative Program
    Kuehn, Bridget M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (08): : 767 - 768
  • [39] Anticoagulation and bleeding: A pooled analysis of lung cancer trials of the National Cancer Institute of Canada Clinical Trials Group
    Le Maitre, A.
    Ding, K.
    Shepherd, F. A.
    Leighl, N. B.
    Arnold, A.
    Seymour, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [40] Factors affecting workload of cancer clinical trials: Results of a multicenter study of the National Cancer Institute of Canada Clinical Trials Group
    Roche, K
    Paul, N
    Smuck, B
    Whitehead, M
    Zee, B
    Pater, J
    Hiatt, MA
    Walker, H
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (02) : 545 - 556
12345